Personalis, Inc. announced the appointment of Lonnie Shoff to the Personalis Board of Directors effective August 2, 2022; Ms. Shoff brings extensive clinical diagnostics experience including executive roles at Thermo Fisher and Roche Diagnostics.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.395 USD | +3.33% | +4.98% | -34.76% |
05-08 | Transcript : Personalis, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Earnings Flash (PSNL) PERSONALIS Reports Q1 Revenue $19.5M, vs. Street Est of $18.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.76% | 70.12M | |
+49.08% | 55.7B | |
+39.58% | 39.91B | |
-6.67% | 39.57B | |
-6.65% | 28.16B | |
+13.82% | 26.3B | |
-21.14% | 18.94B | |
+30.21% | 12.17B | |
+25.90% | 12.12B | |
+0.14% | 12.12B |
- Stock Market
- Equities
- PSNL Stock
- News Personalis, Inc.
- Personalis, Inc. Appoints Lonnie Shoff to Its Board of Directors